Nuformix plc (LON:NFX)
0.1150
-0.0100 (-8.00%)
Sep 12, 2025, 4:25 PM BST
Nuformix Market Cap
Nuformix has a market cap or net worth of 2.49 million as of September 12, 2025. Its market cap has increased by 79.11% in one year.
Market Cap
2.49M
Enterprise Value
2.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 2.49M, a decrease of -85.56%. That is a compound annual growth rate of -21.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 2.30M | 240.43% |
Dec 31, 2024 | 674.17K | -72.13% |
Dec 29, 2023 | 2.42M | 0.30% |
Dec 30, 2022 | 2.41M | -63.56% |
Dec 31, 2021 | 6.62M | -52.25% |
Dec 31, 2020 | 13.86M | -68.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 184.75B |
GSK plc | 59.51B |
Haleon | 32.68B |
Smith & Nephew | 12.46B |
ConvaTec Group | 4.79B |
Hikma Pharmaceuticals | 3.68B |
HUTCHMED (China) | 2.02B |
Genus | 1.76B |